Document is current

Any future updates will be listed below

Recombinant CXCL17 Treatment Alleviates Hyperoxia-Induced Lung Apoptosis and Inflammation In Vivo and Vitro by Activating the AKT Pathway: A Possible Therapeutic Approach for Bronchopulmonary Dysplasia

Crossref DOI link: https://doi.org/10.1007/s12033-023-00866-0

Published Online: 2023-09-14

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark